Consensus EPS · Q2 2026
$7.50
Consensus revenue · Q2 2026
$19.7B
Analysts
8
Expected report
Jul 24, 2026
What to watch
- Analyst ratings: Downgrades trending
Analyst consensus
Based on estimates from 8 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $19.2B | $19.7B | $20.2B |
| EPS | $7.28 | $7.50 | $7.62 |
| EBITDA | $4.1B | $4.2B | $4.3B |
| EBIT | $3.2B | $3.3B | $3.3B |
| Net income | $1.7B | $1.7B | $1.7B |
- Revenue$19.7B
- EPS$7.50
- EBITDA$4.2B
- EBIT$3.3B
- Net income$1.7B
Historical beat/miss
Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.
| Period | Rev. actual | Rev. est. | Rev. surprise | EPS actual | EPS est. | EPS surprise |
|---|---|---|---|---|---|---|
| Q1 2026 | $19.1B | $19.1B | +0.1% | $7.15 | $7.12 | +0.4% |
| Q4 2025 | $19.5B | $19.7B | -0.9% | $8.01 | $7.46 | +7.4% |
- Q1 2026+0.1%+0.4%
- Q4 2025-0.9%+7.4%
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
Revision trends appear once we have collected at least two daily snapshots for this period.
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
Be the first to predict
No community consensus for HCA Healthcare (HCA) Q2 2026 yet. Make a prediction to start the crowd forecast.
Analyst price target
Based on price targets from 8 analysts.
- Low
- $369.00
- Consensus
- $482.31
- Median
- $510.00
- High
- $635.00
- Current
- $371.87
- Upside
- +29.7%
Upside calculated vs most recent trading price of $371.87.
Analyst ratings
Consensus: Buy — based on 46 analyst ratings.
24-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 16, 2026 | Barclays | maintain | Equal Weight | Equal Weight |
| Jul 15, 2026 | RBC Capital | maintain | Outperform | Outperform |
| Jul 14, 2026 | Keybanc | maintain | Overweight | Overweight |
| Jul 13, 2026 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| Jul 8, 2026 | Barclays | downgrade | Overweight | Equal Weight |
| Jul 7, 2026 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| Jun 22, 2026 | TD Cowen | maintain | Buy | Buy |
| Jun 4, 2026 | Bernstein | maintain | Market Perform | Market Perform |
| Apr 27, 2026 | Wells Fargo | maintain | Equal Weight | Equal Weight |
| Apr 27, 2026 | Truist Securities | maintain | Buy | Buy |
- Jul 16, 2026BarclaysEqual Weight
- Jul 15, 2026RBC CapitalOutperform
- Jul 14, 2026KeybancOverweight
- Jul 13, 2026Wells FargoEqual Weight
- Jul 8, 2026BarclaysEqual Weight
- Jul 7, 2026Cantor FitzgeraldOverweight
- Jun 22, 2026TD CowenBuy
- Jun 4, 2026BernsteinMarket Perform
- Apr 27, 2026Wells FargoEqual Weight
- Apr 27, 2026Truist SecuritiesBuy
Frequently asked questions
HCA Healthcare (HCA) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.